News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • California ordered companies seeking state contracts to adopt AI safeguards and watermark AI-generated images, with vendor certification proposals due within 120 days.
  • Asian equities were mixed as investors priced risks from the U.S.-Israel war on Iran, keeping regional risk appetite constrained.
  • South Korea's KOSPI posted its largest March decline, led by heavy losses in semiconductor stocks.
  • Positive Chinese PMI data failed to lift mainland and Hong Kong markets.
  • S&P 500 futures spiked overnight on reports the U.S. president may end the Iran war without reopening the Strait of Hormuz.

Latest Articles

C.H. Robinson Rebuts AI Disruption Fears After Sharp Share Drop

C.H. Robinson Rebuts AI Disruption Fears After Sharp Share Drop

C.H. Robinson responded to market worries about artificial intelligence displacing freight brokers after its stock fell 14.5% on Thursday. The company reaffirmed its long-standing investment in AI, detailed productivity gains from its 'Lean AI' program, and pointed to scale, financial strength and consistent outperformance as defenses against disru…

Barclays: AI-driven selloff may keep pressing stocks viewed as vulnerable

Barclays: AI-driven selloff may keep pressing stocks viewed as vulnerable

Barclays cautioned that a rapid, sentiment-fueled market retreat targeting companies judged vulnerable to artificial intelligence could continue in the near term. Analyst Emmanuel Cau said investors are increasingly grouping stocks by perceived AI immunity or vulnerability, creating choppiness across sectors even as earnings momentum holds up.

Oppenheimer Raises Vertex to Outperform, Citing Renal Pipeline Upside

Oppenheimer Raises Vertex to Outperform, Citing Renal Pipeline Upside

Oppenheimer upgraded Vertex Pharmaceuticals from Perform to Outperform and set a $540 price target, citing potential blockbusters in the company’s renal pipeline. The firm highlighted povetacicept and inaxaplin as key drivers of longer-term revenue diversification while noting improved expectations for 2026 and a mixed Q4 2025 earnings report.

BoE Chief Economist Sees Underlying U.K. Inflation Settling Around 2.5%

BoE Chief Economist Sees Underlying U.K. Inflation Settling Around 2.5%

Bank of England Chief Economist Huw Pill said underlying inflation in the U.K. appears to be stabilizing near 2.5% annually, above the BoE's 2% target. Pill made the comment in London and noted that removing a half percentage-point budget effect would leave the April/May forecast at about 2.5%. He recently voted with a narrow majority to keep the B…

P&G CHRO Completes $2.06M Stock Sale, Exercises Options in Parallel

P&G CHRO Completes $2.06M Stock Sale, Exercises Options in Parallel

Balaji Purushothaman, Procter & Gamble’s Chief Human Resources Officer, sold 12,827 shares of common stock on February 11, 2026, for a weighted average price of $160.3093, raising $2,056,287. On the same day he exercised options to acquire 12,827 shares at $91.07, a transaction valued at $1,168,154. Following these moves he directly holds 12,638.80…

Needham Cuts Tyler Technologies Target to $400 After Q4; Buy Rating Intact

Needham Cuts Tyler Technologies Target to $400 After Q4; Buy Rating Intact

Needham reduced its price objective for Tyler Technologies (TYL) to $400 from $750 while keeping a Buy rating following the company's fourth-quarter results. The firm noted solid performance in SaaS bookings, which grew 9.6% year-over-year, and Tyler raised its fiscal 2026 SaaS revenue guide to a midpoint of 21.5%. The stock, however, has fallen ro…

Needham Sticks With Buy on Twilio After Strong Q4; Sets $145 Price Target

Needham Sticks With Buy on Twilio After Strong Q4; Sets $145 Price Target

Needham has reaffirmed a Buy rating on Twilio (NYSE:TWLO) with a $145.00 price target after the company delivered better-than-expected fourth-quarter results. Organic revenue grew 12% in Q4, driven by a high-teens increase in the voice business and a 49% year-over-year rise in Voice AI revenue. Twilio posted EPS of $1.33 on $1.37 billion in revenue…